Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular Track

Polymorphism of the norepinephrine transporter (SLC6A2) gene not related to cardiac sympathetic activity in heart failure patients

Derk Verschure, Frank Baas, Berthe van Eck-Smit, G. Somsen and Hein Verberne
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1643;
Derk Verschure
2Nuclear Medicine Academic Medical Center Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Baas
1Department of Genome Analysis Academic Medical Center Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berthe van Eck-Smit
2Nuclear Medicine Academic Medical Center Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Somsen
3Cardiology Centers of the Netherlands Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hein Verberne
2Nuclear Medicine Academic Medical Center Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1643

Objectives The norepinephrine (NE) transporter (uptake-1), encoded by the SLC6A2 gene, is responsible for reuptake of NE into presynaptic nerve terminals and regulates NE homeostasis. However, it is unknown if polymorphisms of SLC6A2 influence cardiac myocardial sympathetic activity. 123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy has been extensively validated and clinically used to evaluate cardiac sympathetic function in different cardiac diseases. The influence of SLC6A2 single-nucleotide polymorphisms (SNP) on the 123I-mIBG scintigraphy parameters in patients with heart failure (HF) was studied.

Methods Forty-nine patients with stable HF (age 66.5±8.1 years, LVEF 22.3±6.4 and functional class NYHA 2.3±0.4) referred for 123I-mIBG scintigraphy were enrolled. Fifteen minutes (early H/M) and 4 hours (late H/M) after administration of 185 MBq 123I-mIBG anterior planar thoracic images were acquired using a gamma-camera equipped with medium energy collimators. In addition, washout (WO) was calculated. DNA was extracted from whole-blood samples. Fourteen exons of the SLC6A2 gene were analysed.

Results The mean early H/M was 2.10±0.39, late H/M 1.81±0.39 and WO 13.7±11.2. Six different SLC6A2 SNPs were identified. Only one SNP was in the coding region but did not cause a change in amino acid formation. The other 5 SNPs were intronic and were predicted not to affect splicing. Only the LVEF was an independent predictor of early H/M (adjusted R2 = 0.063, p = 0.045) and late H/M (adjusted R2 = 0.116, p = 0.010). For WO the NT-proBNP was the only independent predictor (adjusted R2 = 0.074, p = 0.032). SLC6A2 SNPs and NYHA class were not related to early H/M, late H/M and WO.

Conclusions As far as we know this is the first study investigating the association between SLC6A2 gene polymorphism and cardiac sympathetic activity. In this specific HF population polymorphism of SLC6A2 did not explain for variations in cardiac sympathetic activity.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Polymorphism of the norepinephrine transporter (SLC6A2) gene not related to cardiac sympathetic activity in heart failure patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Polymorphism of the norepinephrine transporter (SLC6A2) gene not related to cardiac sympathetic activity in heart failure patients
Derk Verschure, Frank Baas, Berthe van Eck-Smit, G. Somsen, Hein Verberne
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1643;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Polymorphism of the norepinephrine transporter (SLC6A2) gene not related to cardiac sympathetic activity in heart failure patients
Derk Verschure, Frank Baas, Berthe van Eck-Smit, G. Somsen, Hein Verberne
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1643;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular Track

  • To Evaluated the Cardiac Function of Patients with Acute Myocardial Infarction by the Volume and Filling Curve of 99mTc-MIBI SPECT Myocardial Perfusion Imaging
  • Standard versus low-dose rubidium-82 dynamic positron emission tomography imaging with scanner-dependent bias correction for myocardial perfusion imaging and blood flow quantification
  • Evaluation of sympathetic function with PET 11C-hydroxyephedrine (HED) and ammonia (13N-NH3) in a canine pacing model of atrial fibrillation
Show more Cardiovascular Track

MTA II: Cardiovascular Basic Science Posters

  • Radionuclide functional assay for in vitro metabolic status during cardiac differentiation in human induced pluripotent stem cells
  • Metabolic Aspects of [14C]Acetate in Rabbit Atherosclerotic Arteries at Different Feeding Conditions: In Vitro Evaluation for Atherosclerosis Imaging with [11C]Acetate
  • SPECT and Fluorescence Imaging of Vulnerable Atherosclerotic Plaque with a Vascular Cell Adhesion Molecule-1 Single-chain Antibody Fragment
Show more MTA II: Cardiovascular Basic Science Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire